SCHEMBL1955346

SCHEMBL1955346

CN(c1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CC(C)(C)CC4)CC3)cc2Oc2ccc3[nH]cc(CCNC(=O)O)c3c2)cc1[N+](=O)[O-])C1CCOCC1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 9/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2505086 0.94 BCL2 (0.71) BCL2
SCHEMBL1957091 0.92 BCL2 (0.82) BCL2
SCHEMBL1955341 0.91 BCL2 (0.89) BCL2
SCHEMBL2481508 0.87 BCL2 (0.73) BCL2
SCHEMBL1959968 0.87 BCL2 (0.89) BCL2
SCHEMBL1958233 0.86 BCL2 (0.82) BCL2
SCHEMBL2777031 0.86 BCL2 (0.72) BCL2
SCHEMBL2505092 0.85 BCL2 (0.85) BCL2
SCHEMBL1957488 0.85 BCL2 (0.76) BCL2
SCHEMBL1955783 0.85 BCL2 (1.00) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507211-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 — — EP disclosed
WO-2011068560-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 — — WO disclosed
Send feedback